Chevron Corporation (NYSE:CVX)
Chevron Corporation is one of the world’s leading integrated energy companies. Through its subsidiaries that conduct business worldwide, the company is involved in virtually every facet of the energy industry. Chevron explores for, produces and transports crude oil and natural gas; refines, markets and distributes transportation fuels and lubricants; manufactures and sells petrochemicals and additives; generates power; and develops and deploys technologies that enhance business value in every aspect of the company’s operations.
Chevron Corporation (NYSE:CVX)’s Financial Overview
Chevron Corporation (NYSE) declined -0.8% yesterday to close its trading session at $112.54. The company has 1 year Price Target of $138.65. Chevron Corporation has 52-Week high of $133.88 and 52-Week Low of $100.22. The stock touched its 52-Week High on 133.88 and 52-Week Low on 100.22. The stock traded with the volume of 4.47 Million shares yesterday. The firm shows the market capitalization of $216.78 Billion.
Chevron Corporation (NYSE) reported its last quarterly earnings on 9/29/2018 where the firm reported its Actual EPS of $2.11/share against the analyst consensus estimate of $2.06/share. The difference between the actual and expected EPS is $0.05 a share with a surprise factor of 2.4%.
The firm is trading with SMA20 of 2.28 Percent, SMA50 of -1.15 Percent and SMA200 of -6.25 percent. Chevron Corporation has P/S value of 1.4 while its P/B value stands at 1.39. Similarly, the company has Return on Assets of 5.5 percent, Return on Equity of 9.4 percent and Return on Investment of 1.7 Percent. The company shows Gross Margin and Operating Margin of 40.9 percent and 8.4 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 2 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 22 analysts offering 12-month price forecasts for Chevron Corp have a median target of 136.00, with a high estimate of 160.00 and a low estimate of 125.00. The median estimate represents a +20.85% increase from the last price of 112.54.
Chevron Corporation is expected* to report earnings on 02/01/2019 before market open. The report will be for the fiscal Quarter ending Dec 2018. According to Zacks Investment Research, based on 6 analysts’ forecasts, the consensus EPS forecast for the quarter is $2.02. The reported EPS for the same quarter last year was $0.73.
Eli Lilly and Company (NYSE:LLY)
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Eli Lilly and Company (NYSE:LLY)’s Financial Outlook
The 16 analysts offering 12-month price forecasts for Eli Lilly and Co have a median target of 120.00, with a high estimate of 136.00 and a low estimate of 93.00. The median estimate represents a +3.29% increase from the last price of 116.18.
Eli Lilly and Company is estimated to report earnings on 01/30/2019. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 5 analysts’ forecasts, the consensus EPS forecast for the quarter is $1.37. The reported EPS for the same quarter last year was $1.14.
According to Zacks Investment Research, Eli Lilly and Company has a Consensus Recommendation of 1.83. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).
The Stock surged 0.21% and closed its last trading session at $116.18. The company has the market capitalization of $122.82 Billion. The stock has 52-week high of $119.84 and 52-Week low of $73.69. The firm touched its 52-Week high on 119.84 and 52-Week low on 73.69. The company has volume of 2.65 Million shares. The company has a total of 1.06 Billion shares outstanding.
Eli Lilly and Company (NYSE) in the last quarter reported its actual EPS of $1.39/share where the analyst estimated EPS was $1.35/share. The difference between the actual and Estimated EPS is $0.04. This shows a surprise factor of 3 percent.
The company has YTD performance of 0.4 percent. Beta for Eli Lilly and Company stands at 0.34 while its ATR (average true range) is 2.8. The company has Weekly Volatility of 2.04%% and Monthly Volatility of 2.56%%.
Eli Lilly and Company has distance from 20-day Simple Moving Average (SMA20) of 3.27%, Distance from 50-Day Simple Moving Average of 3.27 percent and Distance from 200-Day Simple Moving Average of 18.38%.
The Company currently has ROA (Return on Assets) of 1 percent, Return on Equity (ROE) of 3.5 Percent and Return on Investment (ROI) of 6.6% with Gross margin of 73.4 percent and Operating & Profit margin of 12.3% and 1.9% respectively.